Cbdmd Inc Stock Revenue Per Share

YCBD Stock  USD 0.40  0.01  2.98%   
cbdMD Inc fundamentals help investors to digest information that contributes to CbdMD's financial success or failures. It also enables traders to predict the movement of CbdMD Stock. The fundamental analysis module provides a way to measure CbdMD's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CbdMD stock.
Last ReportedProjected for Next Year
Revenue Per Share 5.20  4.94 
As of February 28, 2025, Revenue Per Share is expected to decline to 4.94.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

cbdMD Inc Company Revenue Per Share Analysis

CbdMD's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.

Current CbdMD Revenue Per Share

    
  4.94  
Most of CbdMD's fundamental indicators, such as Revenue Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, cbdMD Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CbdMD Revenue Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for CbdMD is extremely important. It helps to project a fair market value of CbdMD Stock properly, considering its historical fundamentals such as Revenue Per Share. Since CbdMD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CbdMD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CbdMD's interrelated accounts and indicators.
0.96-0.82-0.120.850.290.550.80.910.40.960.850.68-0.32-0.380.240.010.950.88-0.370.82
0.96-0.89-0.070.750.20.460.610.930.390.90.880.71-0.43-0.480.330.081.00.94-0.120.87
-0.82-0.890.02-0.59-0.24-0.35-0.44-0.88-0.3-0.72-0.7-0.530.340.41-0.21-0.23-0.89-0.9-0.04-0.7
-0.12-0.070.02-0.61-0.22-0.87-0.23-0.31-0.86-0.21-0.18-0.650.190.45-0.720.66-0.040.11-0.11-0.19
0.850.75-0.59-0.610.40.90.820.850.750.860.730.84-0.29-0.480.5-0.350.730.6-0.350.7
0.290.2-0.24-0.220.40.380.390.410.320.340.220.110.03-0.09-0.240.390.160.31-0.330.14
0.550.46-0.35-0.870.90.380.620.670.880.60.50.83-0.17-0.430.64-0.560.430.27-0.150.48
0.80.61-0.44-0.230.820.390.620.620.320.80.540.460.02-0.070.01-0.20.590.5-0.780.49
0.910.93-0.88-0.310.850.410.670.620.570.880.850.76-0.4-0.540.380.020.920.87-0.070.83
0.40.39-0.3-0.860.750.320.880.320.570.430.430.84-0.23-0.490.79-0.520.360.210.160.42
0.960.9-0.72-0.210.860.340.60.80.880.430.930.67-0.39-0.460.260.030.890.84-0.420.9
0.850.88-0.7-0.180.730.220.50.540.850.430.930.68-0.53-0.580.380.110.870.83-0.131.0
0.680.71-0.53-0.650.840.110.830.460.760.840.670.68-0.3-0.50.83-0.490.70.480.110.68
-0.32-0.430.340.19-0.290.03-0.170.02-0.4-0.23-0.39-0.53-0.30.95-0.35-0.13-0.42-0.53-0.22-0.57
-0.38-0.480.410.45-0.48-0.09-0.43-0.07-0.54-0.49-0.46-0.58-0.50.95-0.520.03-0.46-0.53-0.26-0.62
0.240.33-0.21-0.720.5-0.240.640.010.380.790.260.380.83-0.35-0.52-0.640.320.110.450.42
0.010.08-0.230.66-0.350.39-0.56-0.20.02-0.520.030.11-0.49-0.130.03-0.640.090.39-0.030.09
0.951.0-0.89-0.040.730.160.430.590.920.360.890.870.7-0.42-0.460.320.090.94-0.110.86
0.880.94-0.90.110.60.310.270.50.870.210.840.830.48-0.53-0.530.110.390.94-0.130.82
-0.37-0.12-0.04-0.11-0.35-0.33-0.15-0.78-0.070.16-0.42-0.130.11-0.22-0.260.45-0.03-0.11-0.13-0.07
0.820.87-0.7-0.190.70.140.480.490.830.420.91.00.68-0.57-0.620.420.090.860.82-0.07
Click cells to compare fundamentals

CbdMD Revenue Per Share Historical Pattern

Today, most investors in CbdMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CbdMD's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CbdMD revenue per share as a starting point in their analysis.
   CbdMD Revenue Per Share   
26.8848.9459.5042.7036.4326.6611.944.525.204.94100%
       Timeline  
Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.
Competition

CbdMD Common Stock Shares Outstanding

Common Stock Shares Outstanding

5.21 Million

4.3M5.0M5.2M
At present, CbdMD's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.

CbdMD Revenue Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CbdMD's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CbdMD could also be used in its relative valuation, which is a method of valuing CbdMD by comparing valuation metrics of similar companies.
7.069.57197.4213.58100%
CbdMD is currently under evaluation in revenue per share category among its peers.

CbdMD Fundamentals

Return On Equity-1.35
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Return On Asset-0.16
Profit Margin(0.94) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-50%0%
Operating Margin(0.07) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-150%-100%-50%
Current Valuation2.4 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%
Shares Outstanding4.47 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%5,000%
Shares Owned By Insiders16.11 %
Shares Owned By Institutions3.32 %
Number Of Shares Shorted193.15 K
Price To Earning17.62 X
Price To Book1.54 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Price To Sales0.14 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Revenue19.48 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%200,000%250,000%300,000%350,000%
Gross Profit22.34 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100,000%200,000%300,000%400,000%500,000%600,000%
EBITDA(1.49 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-600%-400%-200%0%200%400%
Net Income(3.7 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-1,000%0%1,000%2,000%3,000%4,000%5,000%6,000%
Cash And Equivalents10.55 M
Cash Per Share0.17 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%10,000%
Total Debt1.27 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%2,500%
Debt To Equity0.11 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%800%
Current Ratio3.47 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%100%200%300%400%
Book Value Per Share0.80 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-3,000%-2,500%-2,000%-1,500%-1,000%-500%
Cash Flow From Operations(352.79 K)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%800%
Short Ratio1.14 X
Earnings Per Share(10.90) X
Target Price2.0
Number Of Employees42
Beta1.99
Market Capitalization1.96 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%400%
Total Asset10.58 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%1,000%2,000%3,000%4,000%5,000%6,000%
Retained Earnings(182.07 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%
Working Capital(2.23 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Net Asset10.58 M

About CbdMD Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze cbdMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CbdMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of cbdMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:
Check out CbdMD Piotroski F Score and CbdMD Altman Z Score analysis.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.90)
Revenue Per Share
7.06
Quarterly Revenue Growth
(0.15)
Return On Assets
(0.16)
Return On Equity
(1.35)
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…